US Stock MarketDetailed Quotes

Karyopharm Therapeutics (KPTI)

Watchlist

8.610
-0.050-0.58%

Close Apr 17 16:00 ET

8.610
0.0000.00%

Post 16:10 ET

194.10MMarket Cap-0.48P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Karyopharm Therapeutics (KPTI) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Total revenue

0.57%146.07M

11.58%34.08M

13.57%44.04M

-11.35%37.93M

-9.39%30.02M

-0.55%145.24M

-9.50%30.54M

7.70%38.78M

13.86%42.79M

-14.40%33.13M

Operating revenue

0.57%146.07M

11.58%34.08M

13.57%44.04M

-11.35%37.93M

-9.39%30.02M

-0.55%145.24M

-9.50%30.54M

7.70%38.78M

13.86%42.79M

-14.40%33.13M

Cost of revenue

-0.97%5.95M

11.50%1.48M

62.54%2.11M

-28.26%1.05M

-31.92%1.3M

21.55%6.01M

-10.43%1.33M

42.70%1.3M

22.70%1.47M

41.45%1.91M

Gross profit

0.64%140.12M

11.58%32.6M

11.87%41.93M

-10.75%36.88M

-8.01%28.71M

-1.32%139.23M

-9.45%29.21M

6.80%37.48M

13.57%41.32M

-16.42%31.22M

Operating expense

-10.77%230.83M

-16.62%50.44M

-10.37%57.15M

-11.77%61.27M

-4.62%61.97M

-4.42%258.67M

-13.67%60.49M

-3.91%63.77M

5.28%69.44M

-4.79%64.97M

Selling and administrative expenses

-8.86%105.21M

-16.25%22.77M

-3.71%26.61M

-8.35%28.48M

-7.44%27.35M

-12.47%115.44M

-11.40%27.19M

-10.30%27.63M

-9.89%31.07M

-17.71%29.55M

-General and administrative expense

-8.86%105.21M

-16.25%22.77M

-3.71%26.61M

-8.35%28.48M

-7.44%27.35M

-12.47%115.44M

-11.40%27.19M

-10.30%27.63M

-9.89%31.07M

-17.71%29.55M

Research and development costs

-12.30%125.62M

-16.92%27.67M

-15.47%30.54M

-14.55%32.79M

-2.28%34.62M

3.23%143.23M

-15.44%33.3M

1.63%36.13M

21.90%38.37M

9.54%35.43M

Operating profit

24.06%-90.71M

42.96%-17.84M

42.09%-15.22M

13.28%-24.39M

1.49%-33.26M

7.79%-119.44M

17.26%-31.28M

15.92%-26.28M

4.91%-28.12M

-9.26%-33.76M

Net non-operating interest income expense

-43.48%-43.08M

-23.55%-12.01M

-9.44%-10.46M

-51.23%-10.62M

-168.08%-9.99M

-133.09%-30.02M

-163.61%-9.72M

-187.48%-9.55M

-137.13%-7.02M

-28.15%-3.73M

Non-operating interest income

-62.53%2.77M

-59.04%607K

-69.81%553K

-68.24%613K

-53.62%1M

-32.38%7.4M

-41.19%1.48M

-33.38%1.83M

-31.66%1.93M

-24.32%2.16M

Non-operating interest expense

22.52%45.85M

12.63%12.62M

-3.31%11.01M

25.47%11.23M

86.85%10.99M

57.08%37.42M

80.48%11.2M

87.47%11.39M

54.72%8.95M

2.19%5.88M

Other net income (expense)

-185.11%-62.21M

-815.93%-72.41M

-295.62%-7.42M

-103.75%-2.21M

10,014.29%19.82M

20,633.71%73.1M

4,893.36%10.11M

4,160.67%3.79M

196,560.00%59M

174.24%196K

Special income (charges)

-239.51%-62.37M

---62.37M

--0

----

--44.7M

--0

--44.7M

----

-Less:Other special charges

239.51%62.37M

----

---44.7M

--0

----

---44.7M

----

Other non- operating income (expenses)

-99.46%152K

-199.31%-10.04M

-295.62%-7.42M

-115.46%-2.21M

10,014.29%19.82M

8,076.97%28.4M

4,893.36%10.11M

4,160.67%3.79M

47,553.33%14.3M

174.24%196K

Income before tax

-156.66%-196M

-231.07%-102.27M

-3.27%-33.09M

-255.97%-37.21M

37.18%-23.43M

46.51%-76.37M

25.94%-30.89M

7.10%-32.04M

173.41%23.86M

-9.45%-37.29M

Income tax

-24.56%43K

38.53%-67K

21.43%34K

-40.30%40K

-49.30%36K

-82.35%57K

-183.85%-109K

133.33%28K

-47.24%67K

31.48%71K

Net income

-156.52%-196.04M

-232.03%-102.2M

-3.29%-33.13M

-256.57%-37.25M

37.20%-23.46M

46.60%-76.42M

26.43%-30.78M

7.05%-32.07M

172.91%23.79M

-9.48%-37.36M

Net income continuous Operations

-156.52%-196.04M

-232.03%-102.2M

-3.29%-33.13M

-256.57%-37.25M

37.20%-23.46M

46.60%-76.42M

26.43%-30.78M

7.05%-32.07M

172.91%23.79M

-9.48%-37.36M

Minority interest income

Net income attributable to the parent company

-156.52%-196.04M

-232.03%-102.2M

-3.29%-33.13M

-256.57%-37.25M

37.20%-23.46M

46.60%-76.42M

26.43%-30.78M

7.05%-32.07M

172.91%23.79M

-9.48%-37.36M

Preferred stock dividends

Other preferred stock dividends

5.54M

Net income attributable to common stockholders

-156.52%-196.04M

-232.03%-102.2M

-3.29%-33.13M

-304.11%-37.25M

37.20%-23.46M

46.60%-76.42M

26.43%-30.78M

7.05%-32.07M

155.93%18.25M

-9.48%-37.36M

Basic earnings per share

-90.54%-17.93

-58.61%-5.71

0.78%-3.82

-291.15%-4.32

42.89%-2.77

49.92%-9.41

33.82%-3.6

14.44%-3.85

151.95%2.26

-7.78%-4.85

Diluted earnings per share

-28.07%-17.93

-58.61%-5.71

0.78%-3.82

-45.45%-4.32

42.89%-2.77

25.49%-14

33.82%-3.6

14.44%-3.85

31.72%-2.97

-7.78%-4.85

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

Unqualified Opinion

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Total revenue	0.57%146.07M	11.58%34.08M	13.57%44.04M	-11.35%37.93M	-9.39%30.02M	-0.55%145.24M	-9.50%30.54M	7.70%38.78M	13.86%42.79M	-14.40%33.13M
Operating revenue	0.57%146.07M	11.58%34.08M	13.57%44.04M	-11.35%37.93M	-9.39%30.02M	-0.55%145.24M	-9.50%30.54M	7.70%38.78M	13.86%42.79M	-14.40%33.13M
Cost of revenue	-0.97%5.95M	11.50%1.48M	62.54%2.11M	-28.26%1.05M	-31.92%1.3M	21.55%6.01M	-10.43%1.33M	42.70%1.3M	22.70%1.47M	41.45%1.91M
Gross profit	0.64%140.12M	11.58%32.6M	11.87%41.93M	-10.75%36.88M	-8.01%28.71M	-1.32%139.23M	-9.45%29.21M	6.80%37.48M	13.57%41.32M	-16.42%31.22M
Operating expense	-10.77%230.83M	-16.62%50.44M	-10.37%57.15M	-11.77%61.27M	-4.62%61.97M	-4.42%258.67M	-13.67%60.49M	-3.91%63.77M	5.28%69.44M	-4.79%64.97M
Selling and administrative expenses	-8.86%105.21M	-16.25%22.77M	-3.71%26.61M	-8.35%28.48M	-7.44%27.35M	-12.47%115.44M	-11.40%27.19M	-10.30%27.63M	-9.89%31.07M	-17.71%29.55M
-General and administrative expense	-8.86%105.21M	-16.25%22.77M	-3.71%26.61M	-8.35%28.48M	-7.44%27.35M	-12.47%115.44M	-11.40%27.19M	-10.30%27.63M	-9.89%31.07M	-17.71%29.55M
Research and development costs	-12.30%125.62M	-16.92%27.67M	-15.47%30.54M	-14.55%32.79M	-2.28%34.62M	3.23%143.23M	-15.44%33.3M	1.63%36.13M	21.90%38.37M	9.54%35.43M
Operating profit	24.06%-90.71M	42.96%-17.84M	42.09%-15.22M	13.28%-24.39M	1.49%-33.26M	7.79%-119.44M	17.26%-31.28M	15.92%-26.28M	4.91%-28.12M	-9.26%-33.76M
Net non-operating interest income expense	-43.48%-43.08M	-23.55%-12.01M	-9.44%-10.46M	-51.23%-10.62M	-168.08%-9.99M	-133.09%-30.02M	-163.61%-9.72M	-187.48%-9.55M	-137.13%-7.02M	-28.15%-3.73M
Non-operating interest income	-62.53%2.77M	-59.04%607K	-69.81%553K	-68.24%613K	-53.62%1M	-32.38%7.4M	-41.19%1.48M	-33.38%1.83M	-31.66%1.93M	-24.32%2.16M
Non-operating interest expense	22.52%45.85M	12.63%12.62M	-3.31%11.01M	25.47%11.23M	86.85%10.99M	57.08%37.42M	80.48%11.2M	87.47%11.39M	54.72%8.95M	2.19%5.88M
Other net income (expense)	-185.11%-62.21M	-815.93%-72.41M	-295.62%-7.42M	-103.75%-2.21M	10,014.29%19.82M	20,633.71%73.1M	4,893.36%10.11M	4,160.67%3.79M	196,560.00%59M	174.24%196K
Special income (charges)	-239.51%-62.37M	---62.37M	--0	--0	----	--44.7M	--0	--0	--44.7M	----
-Less:Other special charges	239.51%62.37M	----	----	----	----	---44.7M	--0	----	---44.7M	----
Other non- operating income (expenses)	-99.46%152K	-199.31%-10.04M	-295.62%-7.42M	-115.46%-2.21M	10,014.29%19.82M	8,076.97%28.4M	4,893.36%10.11M	4,160.67%3.79M	47,553.33%14.3M	174.24%196K
Income before tax	-156.66%-196M	-231.07%-102.27M	-3.27%-33.09M	-255.97%-37.21M	37.18%-23.43M	46.51%-76.37M	25.94%-30.89M	7.10%-32.04M	173.41%23.86M	-9.45%-37.29M
Income tax	-24.56%43K	38.53%-67K	21.43%34K	-40.30%40K	-49.30%36K	-82.35%57K	-183.85%-109K	133.33%28K	-47.24%67K	31.48%71K
Net income	-156.52%-196.04M	-232.03%-102.2M	-3.29%-33.13M	-256.57%-37.25M	37.20%-23.46M	46.60%-76.42M	26.43%-30.78M	7.05%-32.07M	172.91%23.79M	-9.48%-37.36M
Net income continuous Operations	-156.52%-196.04M	-232.03%-102.2M	-3.29%-33.13M	-256.57%-37.25M	37.20%-23.46M	46.60%-76.42M	26.43%-30.78M	7.05%-32.07M	172.91%23.79M	-9.48%-37.36M
Minority interest income
Net income attributable to the parent company	-156.52%-196.04M	-232.03%-102.2M	-3.29%-33.13M	-256.57%-37.25M	37.20%-23.46M	46.60%-76.42M	26.43%-30.78M	7.05%-32.07M	172.91%23.79M	-9.48%-37.36M
Preferred stock dividends
Other preferred stock dividends									5.54M
Net income attributable to common stockholders	-156.52%-196.04M	-232.03%-102.2M	-3.29%-33.13M	-304.11%-37.25M	37.20%-23.46M	46.60%-76.42M	26.43%-30.78M	7.05%-32.07M	155.93%18.25M	-9.48%-37.36M
Basic earnings per share	-90.54%-17.93	-58.61%-5.71	0.78%-3.82	-291.15%-4.32	42.89%-2.77	49.92%-9.41	33.82%-3.6	14.44%-3.85	151.95%2.26	-7.78%-4.85
Diluted earnings per share	-28.07%-17.93	-58.61%-5.71	0.78%-3.82	-45.45%-4.32	42.89%-2.77	25.49%-14	33.82%-3.6	14.44%-3.85	31.72%-2.97	-7.78%-4.85
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion	--	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm